Susceptibility of lung cancer patients to COVID‐19: A review of the pandemic data from multiple nationalities
Abstract Several studies have highlighted that cancer patients tend to be more susceptible to develop severe infection and to die from COVID‐19. Certain medical conditions such as immunosuppression, presence of comorbidities, and underlying pulmonary damage are possible determinants of disease sever...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-10-01
|
| Series: | Thoracic Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/1759-7714.14067 |
| _version_ | 1818936826947174400 |
|---|---|
| author | Ana Emília Goulart Lemos Gabriela Ribeiro Silva Etel Rodrigues Pereira Gimba Aline da Rocha Matos |
| author_facet | Ana Emília Goulart Lemos Gabriela Ribeiro Silva Etel Rodrigues Pereira Gimba Aline da Rocha Matos |
| author_sort | Ana Emília Goulart Lemos |
| collection | DOAJ |
| description | Abstract Several studies have highlighted that cancer patients tend to be more susceptible to develop severe infection and to die from COVID‐19. Certain medical conditions such as immunosuppression, presence of comorbidities, and underlying pulmonary damage are possible determinants of disease severity, especially in lung cancer patients. While recent studies have shown that lung cancer is one of the most prevalent tumor types among COVID‐19 cancer patients, we still have an incomplete view of how data from several countries work as a whole. The aim of this review was to investigate COVID‐19 prevalence in lung cancer patient cohorts and their probability to develop severe illness and death when compared to nonlung cancer patients from multiple nationalities, including countries that have been the epicenters of the pandemic. We also focus on some intrinsic lung cancer features that might influence COVID‐19 outcomes. An integrative view of the susceptibility of lung cancer patients might be especially relevant to assist physicians in evaluating the risks of COVID‐19 in these patients, and to foster better decisions on treatment delay. |
| first_indexed | 2024-12-20T05:42:15Z |
| format | Article |
| id | doaj.art-42a220791b7f4c499d653b96f6956f3f |
| institution | Directory Open Access Journal |
| issn | 1759-7706 1759-7714 |
| language | English |
| last_indexed | 2024-12-20T05:42:15Z |
| publishDate | 2021-10-01 |
| publisher | Wiley |
| record_format | Article |
| series | Thoracic Cancer |
| spelling | doaj.art-42a220791b7f4c499d653b96f6956f3f2022-12-21T19:51:25ZengWileyThoracic Cancer1759-77061759-77142021-10-0112202637264710.1111/1759-7714.14067Susceptibility of lung cancer patients to COVID‐19: A review of the pandemic data from multiple nationalitiesAna Emília Goulart Lemos0Gabriela Ribeiro Silva1Etel Rodrigues Pereira Gimba2Aline da Rocha Matos3Department of Physiology and Pharmacology Biomedical Institute, Federal Fluminense University (UFF) Niteroi BrazilDepartment of Physiology and Pharmacology Biomedical Institute, Federal Fluminense University (UFF) Niteroi BrazilDepartment of Physiology and Pharmacology Biomedical Institute, Federal Fluminense University (UFF) Niteroi BrazilOswaldo Cruz Institute, Respiratory and Measles Viruses Laboratory/SARS‐CoV‐2 Reference, Laboratory, MoH World Health Organization (WHO), FIOCRUZ Rio de Janeiro BrazilAbstract Several studies have highlighted that cancer patients tend to be more susceptible to develop severe infection and to die from COVID‐19. Certain medical conditions such as immunosuppression, presence of comorbidities, and underlying pulmonary damage are possible determinants of disease severity, especially in lung cancer patients. While recent studies have shown that lung cancer is one of the most prevalent tumor types among COVID‐19 cancer patients, we still have an incomplete view of how data from several countries work as a whole. The aim of this review was to investigate COVID‐19 prevalence in lung cancer patient cohorts and their probability to develop severe illness and death when compared to nonlung cancer patients from multiple nationalities, including countries that have been the epicenters of the pandemic. We also focus on some intrinsic lung cancer features that might influence COVID‐19 outcomes. An integrative view of the susceptibility of lung cancer patients might be especially relevant to assist physicians in evaluating the risks of COVID‐19 in these patients, and to foster better decisions on treatment delay.https://doi.org/10.1111/1759-7714.14067COVID‐19lung cancermortalitySARS‐CoV‐2severity |
| spellingShingle | Ana Emília Goulart Lemos Gabriela Ribeiro Silva Etel Rodrigues Pereira Gimba Aline da Rocha Matos Susceptibility of lung cancer patients to COVID‐19: A review of the pandemic data from multiple nationalities Thoracic Cancer COVID‐19 lung cancer mortality SARS‐CoV‐2 severity |
| title | Susceptibility of lung cancer patients to COVID‐19: A review of the pandemic data from multiple nationalities |
| title_full | Susceptibility of lung cancer patients to COVID‐19: A review of the pandemic data from multiple nationalities |
| title_fullStr | Susceptibility of lung cancer patients to COVID‐19: A review of the pandemic data from multiple nationalities |
| title_full_unstemmed | Susceptibility of lung cancer patients to COVID‐19: A review of the pandemic data from multiple nationalities |
| title_short | Susceptibility of lung cancer patients to COVID‐19: A review of the pandemic data from multiple nationalities |
| title_sort | susceptibility of lung cancer patients to covid 19 a review of the pandemic data from multiple nationalities |
| topic | COVID‐19 lung cancer mortality SARS‐CoV‐2 severity |
| url | https://doi.org/10.1111/1759-7714.14067 |
| work_keys_str_mv | AT anaemiliagoulartlemos susceptibilityoflungcancerpatientstocovid19areviewofthepandemicdatafrommultiplenationalities AT gabrielaribeirosilva susceptibilityoflungcancerpatientstocovid19areviewofthepandemicdatafrommultiplenationalities AT etelrodriguespereiragimba susceptibilityoflungcancerpatientstocovid19areviewofthepandemicdatafrommultiplenationalities AT alinedarochamatos susceptibilityoflungcancerpatientstocovid19areviewofthepandemicdatafrommultiplenationalities |